PATENT CLAIM ANALYSIS

Application Number: 16055560
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "243000"]

Abstract:
The invention relates to a compound of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful as therapeutic agent for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis. Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, inflammatory bowel diseases, Crohn's disease, Alzheimer's disease, leukemia, osteoarthritis, control of pruritus, chronic respiratory disease or keratoconjunctivitis in mammals.

Claim (Index 23):
A pharmaceutical composition comprising a compound according to  claim 21  or a veterinary acceptable salt thereof, and a pharmaceutical acceptable carrier.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 96.0
- Lexical Diversity: 1.54667
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15119800', '14413425', '16307193', '14559294', '16307410']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7608039814807129
- 35 USC 102 Novelty (BERT): 0.498530345679784
- Combined Prediction Score: 0.73457661790062
- Mean Citation Score: 204.447514
- Max Citation Score: 259.12936
- Similarity Product: 201.474599690094

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test